🔴 LIVE: The Secrets of ProPicks AI Success Revealed + November’s List FREEWatch Now

Miners lend support as rate-sensitive stocks drag Europe

Published 07/05/2017, 05:09 AM
© Reuters. Traders work in front of the German share price index, DAX board, at the stock exchange in Frankfurt
UK100
-
C
-
CSGN
-
ADSGN
-
BHPB
-
PSN
-
GLEN
-
STOXX
-

By Kit Rees

LONDON (Reuters) - European shares edged lower on Wednesday, weighed down by weak healthcare stocks and utilities, although gains among basic resources stocks after an upgrade helped cap losses.

The pan-European STOXX 600 index was down 0.1 percent by 0831 GMT in choppy trade, while the blue chip index also fell 0.1 percent.

Miners rose 0.9 percent, hitting a two-month high after Credit Suisse (SIX:CSGN) upgraded the sector to "overweight" in its latest global equity strategy update, saying the sector was a more rewarding play on higher oil prices, interest rates and inflation.

Glencore (LON:GLEN), which rose 2.2 percent, also supported Britain's commodity-heavy FTSE 100, with BHP Billiton (LON:BLT) in tow as Chinese steel rebar futures rallied.

Among individual movers, British housebuilder Persimmon (LON:PSN) jumped around 3 percent after it reported a 7 percent rise in first-half sales, with the market unaffected by the UK's June general election.

"(There's been) a fair bit of concern regarding the housing sector, what the outlook might be like with the uncertainty caused by the general election and the Brexit negotiations ongoing," Dafydd Davies, partner at Charles Hanover Investments, said.

"However, we do see further upside (to) the housebuilders due to the current shortage of housing stock there is still in the UK."

Shares in Adidas (DE:ADSGN) were the biggest individual gainers, rising 4.3 percent to the top of the STOXX after HSBC said that the sporting goods firm was likely to increase its outlook, upgrading it to "buy".

"We believe the sales growth story and associated margin expansion plan make this stock a very visible compounder," HSBC analysts said in a note.

Interest rate-sensitive utilities and health care stocks were a weak spot, with pharmaceuticals dragged down by GlaxoSmithKline, which fell after a downgrade from Citigroup (NYSE:C) to "neutral" from "buy", citing a slowdown in market for HIV drugs if the Affordable Care Act (ACA) is repealed.

© Reuters. Traders work in front of the German share price index, DAX board, at the stock exchange in Frankfurt

A rise in interest rates has been a focus for markets ever since central banks hinted at a possible tightening in monetary policy, with a rise in bond yields making high dividend-paying stocks less attractive.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.